Published in J Urol on March 01, 2007
Prevalence of kidney stones in the United States. Eur Urol (2012) 9.42
Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States. Kidney Int (2013) 1.72
Epidemiology of urolithiasis: an update. Clin Cases Miner Bone Metab (2008) 1.61
Medical comorbidities associated with pediatric kidney stone disease. Urology (2010) 1.50
Geriatric urolithiasis in the emergency department: risk factors for hospitalisation and emergency management patterns of acute urolithiasis. BMC Nephrol (2012) 1.39
Changes in gender distribution of urinary stone disease. Urology (2009) 1.27
Practice variation in the surgical management of urinary lithiasis. J Urol (2011) 1.16
Metabolic syndrome and urologic diseases. Rev Urol (2010) 1.09
Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis. Urol Res (2010) 1.07
Profile of the brushite stone former. J Urol (2010) 1.04
Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol (2010) 0.99
Difference in urinary stone components between obese and non-obese patients. Urol Res (2010) 0.98
Brushite stone disease as a consequence of lithotripsy? Urol Res (2010) 0.98
Urolithiasis in a rural Wisconsin population from 1992 to 2008: narrowing of the male-to-female ratio. J Urol (2011) 0.96
Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res (2012) 0.93
Association between body mass index and urolithiasis in children. J Urol (2011) 0.92
Epidemiological gender-specific aspects in urolithiasis. World J Urol (2013) 0.89
Changes in stone composition over two decades: evaluation of over 10,000 stone analyses. Urolithiasis (2015) 0.85
Annual Incidence of Nephrolithiasis among Children and Adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol (2016) 0.85
Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Miner Bone Metab (2008) 0.84
Female stone disease: the changing trend. Urol Res (2009) 0.83
Management of urolithiasis in pregnancy. Int J Womens Health (2013) 0.83
Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden. Pediatr Nephrol (2014) 0.82
Demystifying the medical management of nephrolithiasis. Rev Urol (2011) 0.82
Epidemiologic insights into pediatric kidney stone disease. Urol Res (2010) 0.82
Demographic characteristics and metabolic risk factors in Croatian children with urolithiasis. Eur J Pediatr (2013) 0.81
Nutrition in calcium nephrolithiasis. J Transl Med (2013) 0.81
Estimating the nationwide, hospital based economic impact of pediatric urolithiasis. J Urol (2014) 0.81
Raised white cell count in renal colic: Is there a role for antibiotics? Urol Ann (2014) 0.80
Biochemical diagnosis in 3040 kidney stone formers in Argentina. Urolithiasis (2015) 0.79
Nephrolithiasis: Endocrine evaluation. Indian J Endocrinol Metab (2012) 0.79
Clinical, demographic, and laboratory characteristics of children with nephrolithiasis. Urolithiasis (2015) 0.79
Evaluation of biochemical urinary stone composition and its relationship to tap water hardness in Qom province, central Iran. Int J Nephrol Renovasc Dis (2011) 0.78
Urinary stone analysis on 12,846 patients: a report from a single center in China. Urolithiasis (2013) 0.78
When (and how) to surgically treat asymptomatic renal stones. Nat Rev Urol (2012) 0.77
Prevalence of kidney stones in mainland China: A systematic review. Sci Rep (2017) 0.77
Nephrolithiasis in elderly population; effect of demographic characteristics. J Nephropathol (2016) 0.77
Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome? Rev Urol (2015) 0.75
Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. Clin J Am Soc Nephrol (2016) 0.75
CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update. Can Urol Assoc J (2016) 0.75
Kidney stones. BMJ Clin Evid (2009) 0.75
A large 15 - year database analysis on the influence of age, gender, race, obesity and income on hospitalization rates due to stone disease. Int Braz J Urol (2016) 0.75
[Urinary calculi in children in Burkina Faso: about 67 cases]. Pan Afr Med J (2015) 0.75
Kidney stones. BMJ Clin Evid (2011) 0.75
Which anthropometric measurements including visceral fat, subcutaneous fat, body mass index, and waist circumference could predict the urinary stone composition most? BMC Urol (2015) 0.75
Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels. Urolithiasis (2016) 0.75
Compositional analysis of various layers of upper urinary tract stones by infrared spectroscopy. Exp Ther Med (2017) 0.75
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Non-evidence-based ICD implantations in the United States. JAMA (2011) 5.05
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol (2005) 4.69
Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol (2010) 4.50
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med (2004) 3.64
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34
Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA (2011) 3.34
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18
Cost of cancer care: issues and implications. J Clin Oncol (2007) 3.00
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med (2013) 2.86
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA (2007) 2.75
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol (2012) 2.72
The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70
Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA (2010) 2.68
Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med (2008) 2.65
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes (2012) 2.61
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol (2009) 2.58
Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol (2008) 2.55
Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2008) 2.40
Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2005) 2.31
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. Arch Intern Med (2010) 2.28
Economic return of clinical trials performed under the pediatric exclusivity program. JAMA (2007) 2.28
Relationship between patient satisfaction with inpatient care and hospital readmission within 30 days. Am J Manag Care (2011) 2.27
Perceived discrimination and reported delay of pharmacy prescriptions and medical tests. J Gen Intern Med (2005) 2.25
Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. Ann Thorac Surg (2010) 2.24
A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol (2010) 2.21
Clinical outcomes after ureteroscopic lithotripsy in patients who initially presented with urosepsis: matched pair comparison with elective ureteroscopy. J Endourol (2014) 2.17
A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol (2007) 2.16
Comparative effectiveness of beta-blockers in elderly patients with heart failure. Arch Intern Med (2008) 2.15
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol (2009) 2.14
Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation (2009) 2.11
Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006. Arch Intern Med (2010) 2.08
Beyond prone position in percutaneous nephrolithotomy: a comprehensive review. Eur Urol (2008) 2.05
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. Am Heart J (2012) 2.04
Percutaneous management of calculi within horseshoe kidneys. J Urol (2003) 2.04
Urinary diversion in patients with spinal cord injury in the United States. Urology (2012) 2.03
Assessment of temporal trends in mortality with implementation of a statewide ST-segment elevation myocardial infarction (STEMI) regionalization program. Ann Emerg Med (2011) 2.03
Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail (2011) 1.99
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail (2009) 1.95
Promoting quality: the health-care organization from a management perspective. Int J Qual Health Care (2007) 1.94
Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. J Urol (2012) 1.94
The role of stress waves and cavitation in stone comminution in shock wave lithotripsy. Ultrasound Med Biol (2002) 1.92
Renal stone assessment with dual-energy multidetector CT and advanced postprocessing techniques: improved characterization of renal stone composition--pilot study. Radiology (2009) 1.90
Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 1.88
Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med (2008) 1.88
Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. J Urol (2004) 1.85
Pain after percutaneous nephrolithotomy: impact of nephrostomy tube size. J Endourol (2003) 1.83
Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol (2008) 1.82
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.79
Medicine. A portfolio model of drug development for tuberculosis. Science (2006) 1.75
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs. Health Aff (Millwood) (2008) 1.74
Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J (2005) 1.71
Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology (2008) 1.71
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol (2004) 1.70
Reducing the costs of phase III cardiovascular clinical trials. Am Heart J (2005) 1.69
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol (2005) 1.69
Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia. J Urol (2006) 1.67
Prostate-specific antigen screening among young men in the United States. Cancer (2008) 1.66
The effect of dementia on outcomes and process of care for Medicare beneficiaries admitted with acute myocardial infarction. J Am Geriatr Soc (2004) 1.66
Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys. J Endourol (2004) 1.65
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer (2003) 1.65
Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol (2003) 1.64
Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization. Circ Cardiovasc Qual Outcomes (2010) 1.63
Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol (2004) 1.63
Process of care performance measures and long-term outcomes in patients hospitalized with heart failure. Med Care (2010) 1.62
Reduced radiation exposure with the use of an air retrograde pyelogram during fluoroscopic access for percutaneous nephrolithotomy. J Endourol (2011) 1.61